The Health Pulse

Quick Lab Mobile

4.2 (5)
Medicine

🎙️ The Health Pulse – Your quick guide to better health! In under 20 minutes, get expert insights on health and nutrition. Stay informed, and take charge of your wellness with actionable tips. Whether optimizing your health or exploring diagnostics, we keep it simple and insightful. Listen, learn, and take control—one pulse at a time! 🔬✨

3d ago

Episode 147 | The Reason You Wake Up Tired

You slept for eight hours, but you wake up feeling like you barely slept at all. The problem may not be how long you were in bed—it may be what happened during those eight hours. In this episode of The Health Pulse, we explore sleep architecture, the carefully organized sequence of brain states your body cycles through each night, and why timing, continuity, and sleep-stage distribution can matter alongside total sleep duration. We begin with the two major systems governing sleep: homeostatic sleep pressure and the circadian rhythm. Adenosine accumulates during waking hours and contributes to the drive to sleep, while your internal circadian clock helps determine when your brain and body are biologically prepared for sleep and wakefulness. Together, these systems help organize the repeating cycles that structure the night. Then we travel through the major stages of NREM and REM sleep. We explain the transition into lighter sleep and why hypnic jerks can suddenly make you feel as though you're falling. In stage N2, characteristic sleep spindles and K-complexes appear as the brain works to maintain sleep while participating in processes involved in learning and memory. Next comes N3 slow-wave sleep, the deepest stage of NREM sleep. This is when slow synchronized brain activity dominates and important aspects of physical restoration occur, with growth hormone secretion strongly associated with early-night slow-wave sleep. It's also the stage from which waking can produce intense sleep inertia, and where parasomnias such as sleepwalking and night terrors commonly arise. Then the brain enters REM sleep. Brain activity becomes more wake-like, vivid dreaming becomes common, breathing grows more variable, and skeletal muscles enter REM atonia—temporarily suppressing most movement while the brain processes information and emotional experiences. But these stages aren't distributed evenly throughout the night. Deep slow-wave sleep is concentrated earlier, while REM periods become progressively longer toward morning. That means shortening the final portion of your sleep may disproportionately reduce REM-rich sleep, even when your total time in bed doesn't seem dramatically different. We also examine what happens when sleep becomes fragmented. Repeated awakenings can disrupt normal sleep architecture even when someone technically spends seven or eight hours in bed. Over time, inadequate or disrupted sleep can influence cortisol rhythms, appetite regulation, food choices, glucose metabolism, and insulin sensitivity, connecting sleep quality directly with metabolic health. Finally, we look at sleep trackers. Wearables can be useful for observing long-term trends in sleep duration, timing, and consistency, but consumer devices are not equivalent to polysomnography for determining precise sleep stages. Obsessing over imperfect sleep scores can even contribute to orthosomnia, where anxiety about optimizing sleep begins interfering with sleep itself. And sometimes persistent fatigue deserves a deeper investigation. Depending on symptoms and clinical context, tests such as a CBC, ferritin, and iron studies may help uncover contributors such as iron deficiency, while snoring, witnessed breathing pauses, morning headaches, or excessive daytime sleepiness may warrant evaluation for obstructive sleep apnea. Eight hours is a useful number. But restorative sleep is more than a stopwatch—it is an organized biological process your brain has to complete. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
4d ago

Episode 146 | The Normal A1C Trap

Your fasting glucose is normal. Your HbA1c is comfortably below the prediabetes threshold. Everything looks fine—but how much insulin is your pancreas producing to keep those numbers there? In this episode of The Health Pulse, we explore one of the biggest blind spots in metabolic testing: insulin resistance can develop while conventional glucose markers remain normal. Instead of asking only whether glucose is elevated, we look at the metabolic effort required to control it. We begin with the two tests most people know: fasting plasma glucose and HbA1c. HbA1c provides a useful estimate of average glycemic exposure over the preceding months, but an average can conceal very different glucose patterns. Fasting glucose has a different limitation: it's a single snapshot influenced by factors including sleep, stress, illness, hormones, and the dawn phenomenon. Then we introduce the missing variable: insulin. During the early stages of insulin resistance, skeletal muscle, liver, and other tissues may require increasingly larger insulin signals to manage glucose. Pancreatic beta cells can compensate by producing more insulin, creating a state of normoglycemic hyperinsulinemia—normal glucose maintained at the cost of elevated insulin. This is why we examine fasting insulin and its limitations. Insulin assays and reference ranges aren't as standardized as glucose testing, and a single measurement still provides only a snapshot. We explain how HOMA-IR, which combines fasting glucose and fasting insulin, can provide additional information about basal insulin resistance while still requiring appropriate clinical context. Next, we stress-test the system with the oral glucose tolerance test (OGTT). A conventional two-hour glucose result can miss important dynamics occurring earlier in the test. Adding insulin measurements can reveal how quickly and how aggressively the pancreas responds to the glucose challenge—including compensatory insulin responses that may precede overt glucose intolerance. Finally, we explore continuous glucose monitoring (CGM). Research in people without diabetes is beginning to reveal meaningful differences in glucose exposure and variability even among individuals who would otherwise appear metabolically healthy. But CGMs can also create unnecessary anxiety when every transient rise is interpreted as damage. A glucose reading of 145 mg/dL after a meal doesn't tell the entire story. How high glucose rises, how long it remains elevated, how frequently the pattern occurs, what caused it, and how efficiently glucose returns toward baseline all provide important context. The goal isn't to chase a perfectly flat glucose line. It's to understand your metabolic response. By combining tools such as HbA1c, fasting glucose, fasting insulin, HOMA-IR, appropriately selected glucose-tolerance testing, and targeted CGM use, we can ask a much more informative question than “Is my blood sugar normal?” How hard is my metabolism working to keep it normal? 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Sep 17

Episode 145 | What ApoB Alone Can't Tell You

ApoB has transformed how we think about cardiovascular risk because it measures something LDL cholesterol cannot: the number of atherogenic lipoprotein particles circulating in your blood. But once you know the particle count, another question emerges—are all ApoB-containing particles biologically equivalent? In this episode of The Health Pulse, we go beyond the standard cholesterol panel to explore the major families of ApoB-containing lipoproteins, including LDL, triglyceride-rich lipoproteins and their remnants, and lipoprotein(a), or Lp(a). Each carries ApoB, but their composition, metabolism, and biological effects can differ substantially. We begin with the fundamental distinction between cholesterol mass and particle number. LDL-C measures how much cholesterol is being transported within LDL particles, while ApoB provides an estimate of the total number of circulating atherogenic particles. When those measurements become discordant—particularly in people with insulin resistance, elevated triglycerides, or metabolic syndrome—LDL-C alone can underestimate the particle burden. Then we examine Lp(a), a largely genetically determined particle consisting of an LDL-like core attached to apolipoprotein(a). Its distinctive kringle structures and ability to carry oxidized phospholipids may contribute additional inflammatory and vascular effects beyond its cholesterol content, helping explain its association with atherosclerotic cardiovascular disease and calcific aortic valve disease. On the metabolic side, we explore triglyceride-rich lipoproteins and remnant particles. Insulin resistance can increase hepatic VLDL production while disrupting normal triglyceride handling and particle clearance. The result can be a large burden of ApoB-containing remnants even when conventional LDL-C appears reassuring. We then dive into a large European Heart Journal analysis that profiled 2,918 circulating proteins to examine the biological pathways associated with different ApoB-containing lipoproteins. Using UK Biobank data with external replication in MESA, researchers found striking differences in the protein signatures associated with LDL, triglyceride-rich lipoproteins, and Lp(a). Triglyceride-rich particles were associated with hundreds of proteins involving immune activation and vascular remodeling, suggesting that the biology surrounding atherogenic particles may provide additional information beyond simply counting them. These findings don't make ApoB less important. Instead, they add another layer: atherosclerotic risk reflects both the opportunity for ApoB particles to enter the arterial wall and the biological characteristics of the particles and metabolic environment surrounding them. Finally, we translate the science into a practical testing strategy. We discuss ApoB alongside the standard lipid panel, direct Lp(a) measurement, fasting insulin, HbA1c, triglyceride-to-HDL ratio, and hs-CRP. We also explain why Lp(a) results reported in mg/dL and nmol/L should not be converted using a universal fixed formula, because particle composition varies between individuals. If your cardiovascular risk assessment still begins and ends with LDL-C, this episode will show you what may be hiding behind that single cholesterol number—and why understanding the particles carrying cholesterol can reveal a much deeper cardiovascular story 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Sep 16

Episode 144 | Cortisol Rhythms and Insulin Resistance

Insulin resistance isn't necessarily an all-or-nothing condition. Skeletal muscle can become insulin resistant while other tissues continue responding differently—and the pancreas may compensate by producing enough insulin to keep fasting glucose and HbA1c looking completely normal. In this episode of The Health Pulse, we explore a fascinating piece of metabolic research suggesting that when stress hormones are released may matter independently of how much is released. We begin with the normal circadian rhythm of cortisol. Rather than remaining constant throughout the day, cortisol typically rises around the biological morning and declines toward night, with additional ultradian pulses layered onto that daily rhythm. This changing signal helps synchronize metabolism with the body's internal clock. But what happens when that rhythm becomes flattened? We examine a controlled Cell Reports mouse study that manipulated glucocorticoid timing while avoiding the usual confounding effect of simply increasing overall hormone exposure. The animals developed substantial adiposity despite eating a standard diet, but their metabolic dysfunction looked strikingly different from conventional diet-induced obesity. One of the most interesting findings was tissue-specific insulin resistance. Skeletal muscle developed pronounced insulin resistance while adipose tissue retained comparatively greater insulin responsiveness and capacity to store lipid. That altered pattern of fat handling was accompanied by relative protection from the severe fatty liver typically associated with diet-induced metabolic dysfunction. The study provides an important mechanistic lesson, but also an important limitation: these findings come from mice and should not be treated as proof that flattened cortisol rhythms produce the same metabolic phenotype in humans. We then translate the physiology into a broader clinical framework. When skeletal muscle becomes resistant to insulin, pancreatic beta cells can compensate by secreting increasingly large amounts of insulin. This hyperinsulinemia can maintain normal glucose for a considerable period, potentially allowing metabolic dysfunction to develop before conventional glucose markers become abnormal. We also explain why detecting abnormal cortisol timing isn't as simple as ordering one morning cortisol level. A single measurement provides a snapshot, while circadian dysfunction is fundamentally about the shape and timing of a rhythm. Instead of trying to diagnose this physiology from cortisol alone, we discuss metabolic measurements that can provide additional context, including fasting insulin alongside fasting glucose, HOMA-IR, and insulin measurements during an oral glucose tolerance test. Finally, we explore practical signals that help reinforce circadian organization: consistent sleep and wake times, bright light during the biological morning, reducing excessive light exposure at night, appropriate meal timing, and regular physical activity. Resistance training adds another advantage because muscle contraction can stimulate GLUT4 translocation and glucose uptake through pathways involving AMPK that are less dependent on insulin signaling. The takeaway isn't that disrupted cortisol rhythms explain every case of insulin resistance or weight gain. It's that metabolism depends not only on how much of a signal the body receives, but also where and when that signal occurs. Sometimes the first sign of insulin resistance isn't high blood sugar. The body may simply be working much harder to keep that blood sugar looking normal. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Sep 15

Episode 143 | IL-6 and the Hidden Risk of Heart Failure

Your hsCRP comes back in the “normal” range. Does that mean inflammation isn't contributing to your cardiovascular risk? For people with type 2 diabetes, the answer may be more complicated. In this episode of The Health Pulse, we explore emerging evidence connecting interleukin-6 (IL-6), insulin resistance, and heart failure—and why one of the most commonly measured inflammation markers, hsCRP, may not always capture the full story. We begin with the cardiorenal-metabolic connection. Type 2 diabetes doesn't affect glucose in isolation. Insulin resistance, vascular dysfunction, kidney disease, sodium retention, visceral adiposity, and chronic inflammation can interact to increase pressure and volume stress on the heart. Over time, these disturbances can contribute to cardiac remodeling and conditions such as heart failure with preserved ejection fraction (HFpEF). Then we compare two biomarkers that are often discussed as though they measure the same thing: IL-6 and high-sensitivity C-reactive protein (hsCRP). IL-6 is an upstream signaling cytokine produced by multiple tissues and immune cells, including dysfunctional adipose tissue in chronic metabolic disease. CRP sits farther downstream: inflammatory signaling, including IL-6, stimulates the liver to produce it. That distinction may matter when trying to understand the biological processes driving risk rather than simply detecting a generalized inflammatory response. We examine findings from an analysis connected with the long-running Look AHEAD trial, where IL-6 showed a stronger relationship with incident heart failure than hsCRP in adults with type 2 diabetes. The findings raise an important question: could upstream inflammatory signaling reveal cardiometabolic risk that a conventional downstream marker sometimes misses? There is also a more hopeful side to the story. Lifestyle intervention can influence inflammatory biology. Improvements in physical activity, body composition, metabolic health, and visceral adiposity can reduce chronic inflammatory signaling, including IL-6. But IL-6 comes with an important paradox. During exercise, contracting skeletal muscle can temporarily release large amounts of IL-6 as a myokine involved in fuel mobilization and adaptation. That short-lived physiological pulse is very different from persistently elevated IL-6 associated with dysfunctional adipose tissue and chronic immune activation. Context matters. We also explain why IL-6 isn't ready to become a simple standalone screening test. Levels can vary with infection, exercise, timing, inflammatory disease, and other factors, and routine clinical interpretation remains less standardized than established cardiovascular biomarkers. Instead, we zoom out to the broader cardiometabolic picture. Depending on the individual, markers such as HbA1c, fasting insulin, ApoB, eGFR, urine albumin-to-creatinine ratio, and BNP or NT-proBNP can help evaluate different components of metabolic, kidney, vascular, and cardiac risk. The lesson isn't to replace hsCRP with IL-6. It's to recognize that inflammation is a network, not a single number—and a reassuring laboratory result should always be interpreted within the larger metabolic picture. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Sep 14

Episode 142 | The Normal Blood Sugar Trap

What does it actually mean to reverse type 2 diabetes? If medications bring your HbA1c back into the normal range, has the disease improved—or has the glucose simply been controlled? In this episode of The Health Pulse, we examine a revealing clinical trial in people with newly diagnosed type 2 diabetes. An aggressive four-drug strategy normalized glucose in roughly 90% of participants during 16 weeks of treatment. But after the medications were withdrawn, that early advantage did not translate into higher rates of sustained, medication-free remission. That difference exposes one of the most important concepts in metabolic health: normalizing a biomarker while treatment is being taken is not the same as changing the underlying disease state. We begin with HbA1c, one of the most useful tools for diagnosing and monitoring diabetes, but a marker that cannot tell the entire metabolic story by itself. Glucose may improve while insulin resistance, hyperinsulinemia, ectopic fat, fatty liver, and cardiovascular risk remain. We then follow type 2 diabetes deeper into the liver and pancreas. As excess energy begins accumulating in tissues that aren't designed to store large amounts of fat, lipid intermediates can interfere with insulin signaling. The insulin-resistant liver continues releasing glucose while the pancreas compensates by producing more insulin. Over time, increasing metabolic pressure can impair beta-cell function, including the rapid first-phase insulin response needed to control glucose after meals. This helps explain why early intervention matters—and why diabetes risk can't be reduced to BMI alone. We explore the personal fat threshold, the idea that individuals differ in how much fat they can safely store before excess energy begins accumulating ectopically in organs such as the liver and pancreas. From there, we examine strategies capable of reducing that metabolic pressure. Substantial weight loss when appropriate, carbohydrate restriction, resistance training, and metabolic surgery can reach the problem through different mechanisms. We explain how muscle contraction can stimulate glucose uptake through pathways involving AMPK and GLUT4 with less dependence on insulin, and how metabolic surgery can rapidly alter appetite, nutrient signaling, and gut hormones such as GLP-1. Finally, we discuss what deeper metabolic monitoring can add beyond HbA1c, including fasting insulin, HOMA-IR, C-peptide, triglycerides, and ApoB. These markers can provide additional context about insulin demand, endogenous insulin production, lipid metabolism, and cardiovascular risk. Remission is an extraordinary goal, but it shouldn't be confused with a cure. Even after glucose returns to the non-diabetic range without glucose-lowering medication, long-term monitoring remains important because metabolic dysfunction and hyperglycemia can return. If you're tracking type 2 diabetes using HbA1c alone, this episode will help you ask a more important question: are we simply lowering the glucose—or reducing the metabolic pressure that made it rise in the first place? 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Sep 10

Episode 141 | Beyond The Diet Wars

Is keto better because of carbohydrate restriction—or simply because people lose weight? Does a Mediterranean diet have unique metabolic advantages? And if calories and weight loss are identical, does the type of food you eat still matter? In this episode of The Health Pulse, we examine a tightly controlled randomized feeding study published in Cell Metabolism that offers an unusually clear way to investigate those questions. Instead of relying on food diaries, calorie estimates, or participants' ability to follow a diet at home, researchers provided the food and adjusted energy intake so participants following ketogenic, Mediterranean, and very-low-fat plant-forward diets all lost approximately the same 10% of body weight. That design helps separate two variables that nutrition research often struggles to untangle: the metabolic effects of weight loss itself and the effects of macronutrient composition. The results reveal an important organ-specific story. In skeletal muscle, insulin sensitivity improved substantially across the dietary approaches, suggesting that losing excess body fat itself may be a dominant driver of improved muscle glucose metabolism. The liver told a different story. Despite matched weight loss, the ketogenic diet produced substantially greater reductions in liver fat and improvements in hepatic insulin sensitivity. We explore the physiology that may help explain this difference, including changes in insulin and glucagon signaling, reduced carbohydrate availability, and suppression of de novo lipogenesis—the pathway through which the liver converts excess carbohydrate into fatty acids. That distinction matters because fatty liver and hepatic insulin resistance can appear early in the progression toward metabolic disease. We connect these findings with prediabetes, MASLD, fasting insulin, triglycerides, and continuous glucose monitoring, including why normal fasting glucose doesn't necessarily mean glucose regulation is normal throughout the day. We also tackle one of the most controversial parts of ketogenic nutrition: cholesterol. LDL cholesterol and ApoB are related, but they don't measure exactly the same thing. We explain why ApoB provides information about the number of circulating atherogenic particles, why lipid responses to carbohydrate restriction vary substantially between individuals, and why measurements obtained during active weight loss need to be interpreted in context. The larger lesson isn't that researchers have finally discovered one perfect diet. It's that different dietary strategies may produce different metabolic effects even when weight loss is identical—and those differences can matter depending on whether the primary problem is liver fat, insulin resistance, glucose control, cardiovascular risk, or something else. Finally, we discuss how laboratory testing can help personalize the decision, including fasting insulin, HbA1c, triglycerides, ApoB, liver enzymes, and CGM data, along with an important safety consideration for people taking glucose-lowering medications. In particular, combining substantial carbohydrate restriction with SGLT2 inhibitors can increase the risk of euglycemic diabetic ketoacidosis and requires appropriate medical guidance. If you're tired of hearing that either carbohydrates, fat, or calories explain everything, this episode offers a more useful framework: weight loss matters—but macronutrients can still influence what happens inside individual organs. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Sep 8

Episode 140 | Where Does Morning Glucose Come From on Keto?

Here are the episode description and companion blog embed intro. I’d keep the distinction between physiological glucose sparing and pathological insulin resistance central to this one. 🎙️ The Health Pulse – Episode Title: Why Is My Fasting Glucose High on Keto? The Dawn Phenomenon Explained Episode Description: Your CGM stays nearly flat all day. You're eating very few carbohydrates. You're producing ketones. Then you wake up and your fasting glucose is unexpectedly high. Where did that glucose come from? In this episode of The Health Pulse, we explore the physiology behind elevated morning glucose on a ketogenic or very-low-carbohydrate diet and explain why a higher fasting glucose doesn't automatically mean your diet has stopped working—or that you've developed diabetes. We begin with the dawn phenomenon. Sleep isn't metabolically inactive. As morning approaches, your circadian system coordinates changes in hormones including cortisol, growth hormone, glucagon, and catecholamines, signaling the liver to increase glucose availability in preparation for waking. That glucose doesn't have to come from last night's carbohydrates. Even during nutritional ketosis, the body maintains some circulating glucose. Through gluconeogenesis, the liver can produce it from substrates including glycerol, lactate, and glucogenic amino acids. We explain why this process is highly regulated and why the popular claim that “too much protein just turns into sugar” oversimplifies the physiology. Then we tackle the more complicated question: when is elevated fasting glucose a normal adaptation, and when should it raise concern? During prolonged carbohydrate restriction, skeletal muscle can reduce its reliance on glucose and preferentially use fatty acids, helping preserve glucose for tissues with greater glucose requirements—a phenomenon often described as adaptive glucose sparing. We examine this concept alongside controlled research showing that ketogenic diets can alter glucose tolerance, highlighting why a single glucose reading cannot tell you whether the underlying physiology is healthy or pathological. The metabolic context matters. We discuss how fasting insulin, HbA1c, triglycerides, ketones, HOMA-IR, and C-peptide, together with CGM patterns and clinical context, can help distinguish compensatory hyperinsulinemia and metabolic dysfunction from a low-insulin, carbohydrate-restricted state. We also explain why morning glucose needs a clean baseline. Poor sleep, sleep apnea, psychological stress, late-night meals, intense evening exercise, caffeine, illness, and normal day-to-day hormonal variation can all influence what appears on your meter the next morning. The takeaway is simple: don't diagnose your metabolism from one fasting glucose value. A morning glucose reading is one frame of a much larger metabolic movie. If you're following keto, low-carb, or using a CGM to understand your metabolism, this episode will help you interpret that mysterious morning rise with physiology instead of fear. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.

4.2

out of 5

5 Ratings

🎙️ The Health Pulse – Your quick guide to better health! In under 20 minutes, get expert insights on health and nutrition. Stay informed, and take charge of your wellness with actionable tips. Whether optimizing your health or exploring diagnostics, we keep it simple and insightful. Listen, learn, and take control—one pulse at a time! 🔬✨

Creator

Quick Lab Mobile
Years Active

2025 - 2026
Episodes

147
Rating

Clean
Copyright

© 2026 Quick Lab Mobile
Show Website

The Health Pulse

Nutrition

Nutrition

Updated Weekly
Health & Fitness

Health & Fitness

Updated Biweekly